SCHEMBL22673263

SCHEMBL22673263

C=Cc1cc(N2CCCNCC2)ccc1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 4/20 0.58
CHRNB2 P17787 10/20 0.47
CHRNA4 P43681 10/20 0.47
HTR7 P34969 4/20 0.46
HTR3A P46098 3/20 0.42
HTR3E A5X5Y0 1/20 0.42
HTR3B O95264 1/20 0.42
HTR5A P47898 1/20 0.42
HTR3D Q70Z44 1/20 0.42
HTR3C Q8WXA8 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
HTR1A P08908 3/20 0.42
HTR1D P28221 2/20 0.41
HTR2A P28223 2/20 0.41
HTR2B P41595 2/20 0.41
HTR6 P50406 2/20 0.41
HTR1B P28222 1/20 0.41
HTR2C P28335 1/20 0.41
CHRNA1 P02708 1/20 0.40
CHRNA7 P36544 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27820991 0.86 MEN1 (0.48) ADRB1
SCHEMBL27844755 0.85 ALDH1A1 (0.48) ADRB1
SCHEMBL27862517 0.83 ADRB1 (0.46) ADRB1HTR3A
SCHEMBL5231120 0.82 ADRB1 (0.86) ADRB1CHRNB2CHRNA4HTR7HTR3A
SCHEMBL21533600 0.79 ADRB1 (0.65) ADRB1CHRNB2CHRNA4HTR7HTR3A
SCHEMBL5238705 0.78 ADRB1 (0.63) ADRB1CHRNB2CHRNA4HTR7HTR3A
SCHEMBL22818466 0.75 ADRB1 (0.59) ADRB1CHRNB2CHRNA4HTR7HTR3A
SCHEMBL5206787 0.75 ADRB1 (0.63) ADRB1CHRNB2CHRNA4HTR7HTR3A
SCHEMBL5235956 0.75 ADRB1 (0.63) ADRB1CHRNB2CHRNA4HTR7HTR3A
SCHEMBL221254 0.74 ADRB1 (1.00) ADRB1HTR7HTR3AHTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020231806-A1 PHENYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF DECIPHERA PHARMACEUTICALS, LLC (US) 2020-11-19 WO disclosed